期刊文献+

Th22细胞在卵巢癌恶性腹水中募集的机制 被引量:4

Recruitment mechanism of Th22 cells in malignant ascites of ovarian cancer
暂未订购
导出
摘要 目的观察Th22细胞在卵巢癌恶性腹水(MA)中的分布情况,探讨其向腹腔内募集的可能机制。方法选择卵巢癌合并MA患者23例(观察组)、健康女性13例(对照组),用密度梯度离心法获得MA和外周血中单个核细胞,流式细胞仪检测MA和外周血中Th22、Th17细胞构成比及Th22细胞趋化因子表达水平,ELISA法检测腹水上清液和外周血中IL-17、IL-22的水平,用Spearman秩相关分析变量间关系。结果观察组MA中Th22、Th17细胞构成比高于同组外周血和对照组外周血(P均<0.05);观察组MA中CCR4、CCR7、CD45RO型Th22细胞构成比高于外周血,CD45RA、CD62L型低于外周血(P均<0.05);MA中IL-17、IL-22水平高于同组外周血及对照组外周血(P均<0.05);经Spearman秩相关分析,MA中Th22细胞与Th17细胞构成比呈正相关(r=0.66,P<0.01),IL-22水平与Th22细胞、Th17细胞构成比呈正相关(r分别为0.55、0.54,P均<0.05)。结论 Th22细胞可能通过趋化因子与炎症细胞因子由外周血向卵巢癌MA中募集。 Objective To observe the distribution of Th22 cells in malignant ascites( MA) of ovarian cancer and to investigate its recruitment mechanism in the abdominal cavity. Methods Twenty-three cases of ovarian cancer patients with MA( observation group) and 13 healthy women( control group) were selected. Density gradient centrifugation was used to collect the mononuclear cells from MA and peripheral blood. The proportion of Th17 and Th22 cells from MA and peripheral blood,and the expression of chemokines in Th22 cells were detected by flow cytometry. The levels of IL-17 and IL-22 in MA and supernatant were examined by ELISA,and the correlations between Th22 cells and Th17 cells were determined by Spearman 's rank correlation coefficients. Results The proportion of Th22 and Th17 cells in MA was significantly higher than that in peripheral blood from the observation group and control group( all P〈0. 05). In the observation group,the proportions of Th22 cells in MA with CCR4,CCR7 and CD45 RO were higher and the proportions of Th22 cells in MA with CD45 RA and CD62 L were lower than those in the peripheral blood( all P〈0. 05). The levels of IL-17 and IL-22 in MA were higher than those from the peripheral blood in the observation group and control group( all P〈0. 05). Spearman's rank correlation coefficients showed that the proportion of Th22 cells was positively correlated with the proportion of Th17 cells in MA( r = 0. 66,P 〈0. 01),the level of IL-22 had a positive correlation with the proportion of Th22 cells and Th17 cells in MA( r = 0. 55,0. 54; all P〈0. 05). Conclusions Th22 cells may be recruited from peripheral blood to MA of ovarian cancer by chemokines and cytokines.
出处 《山东医药》 CAS 北大核心 2016年第9期7-9,共3页 Shandong Medical Journal
基金 国家自然科学基金资助项目(81260083 31360221)
关键词 卵巢肿瘤 恶性腹水 辅助T细胞22 细胞分化 细胞募集 ovarian neoplasms malignant ascites helper T cells 22 cell differentiation cell recruitment
  • 相关文献

参考文献10

  • 1Duhen T, Geiger R, Jarrossay D, et al. Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memo- ry T cells[J]. Nat Immunol, 2009,10(8) :857-863.
  • 2Eyerich S, Eyerich K, Pennino D, et al. Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling[ J]. J Clin Invest, 2009,119 (12) :3573.
  • 3Wolf D, Wolf AM, Rumpold H, et al. The expression of the regu- latory T cell-specific forkhead box transcription factor FoxP3 is as- sociated with poor prognosis in ovarian cancer [ J ]. Clin Cancer Res, 2005,11 ( 23 ) :8326-8331.
  • 4姚海荣,田菁,李迎春,张文琪,郝权.卵巢癌腹水CD4+CD25+调节性T细胞免疫抑制功能及机制的研究[J].中国肿瘤临床,2014,41(9):560-565. 被引量:7
  • 5Ye Z J, Zhou Q, Gu YY, et al. Generation and differentiation of IL-17-producing CIM + T cells in malignant pleural effusion[J]. J Immunol, 2010,185 ( 10 ) :6348-6354.
  • 6Zhang N, Pan HF, Ye DQ. Th2t2 in inflammatory and autoimmune disease: prospects for therapeutic intervention [ J ]. Mol Cell Bio- chem, 2011,353(1-2) :41-46.
  • 7Jiang R, Tan Z, Deng L, et al. Interleukin-22 promotes human hepatocellular carcinoma by activation of STAT3 [ J ]. Hepatology, 2011,54(3) :900-909.
  • 8Wang Z, Yang L, Jiang Y, et al. High fat diet induces formation of spontaneous liposarcoma in mouse adipose tissue with overex- pression of interleukin 22[J]. PLoS One, 2011,6(8) :e23737.
  • 9Zhuang Y, Peng LS, Zhao YL, et al. Increased intratumoral IL- 22-producing CD4 T cells and Th22 cells correlate with gastric cancer progression and predict poor patient survival [ J ]. Cancer Immunol Immunother, 2012, 61 ( 11 ) : 1965-1975.
  • 10Ye ZJ, Zhou Q, Yin W, et al. Interleukin 22-producing CD4 + T cells in malignant pleural effusion [ J ]. Cancer Lett, 2012,326 ( 1 ) :23-32.

二级参考文献17

  • 1Whiteside TL. What are regulatory T cells (Treg) regulating in can- cer and why[J]? Semin Cancer Biol, 2012, 22(4):327-34.
  • 2Weiss VL, Lee TH, Jaffee EM, et al. Targeting the right regulatory T-cell population for tumor immunotherapy[J]. Oncoimmunolo- gy, 2012, 1(7):1191-1193.
  • 3Wolf AM, Wolf D, Steurer M. Increase of regulatory T cells in the peripheral blood of cancer patients[J]. Clin Cancer Res, 2003, 9(2):606.
  • 4Lee SW, Kim YM, Lee HY, et al. Proliferation of CD4 + CD25 + Foxp3+ regulatory T lymphocytes in ex vivo expanded ascitic fluid from primary and recurrent ovarian carcinoma[J]. J Gynecol Oncol, 2010, 21(1):38-44.
  • 5Tanchot C, Terme M, Pere H, et al. Tumor-infiltrating regulatory T cells: phenotype, role, mechanism of expansion in situ and clini- cal significance[J]. Cancer Microenviron, 2013, 6(2):147-157.
  • 6Cruriel TJ, Coukos G, Zou L, et al. Specific recruitment of regulato- ry T cells in ovarian carcinoma fosters immune privilege and pre- dicts reduced survival[J]. Nat Med, 2004,10(9):942-949.
  • 7Savage PA, Malchow S, Leventhal DS. Basic principles of tu- mor-associated regulatory T cell biology[J]. Trends Immunol, 2013, 34(1):33-40.
  • 8Darrasse-J:ze G, Podsypanina K. How numbers, nature, and immune status of Foxp3+ regulatory T-Cells shape the early immunological events in tumor development[J]. Front Immunol, 2013, 4:292.
  • 9Shigematsu Y, Hanagiri T, Shiota H, et al. Immunosuppressive ef- fect of regulatory T lymphocytes in lung cancer, with special refer- ence to their effects on the induction of autologous tumor-specific cytotoxic T lymphocytes[J]. Oncol Lett, 2012, 4(4):625-630.
  • 10Sato E, Olson SH, AhnJ, et al. Intraepithelial CD8+tumor-infiltrat- ing lymphocytes and a high CD8+/regulatory T cell ratio are associ- ated with favorable prognosis in ovarian cancer[J]. Proc Natl Acad Sci USA, 2005, 102(51):18538-18543.

共引文献6

同被引文献35

引证文献4

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部